Deadline: 17-Nov-23
ViiV Healthcare is excited to announce an opportunity to engage the support of a research entity to complete a research study of Positive Action Grants awarded under the 2023 Innovator call ‘Harm reduction and HIV prevention, care and treatment for communities who engage in Chemsex’.
The research study will provide a credible source of evidence on the effectiveness of the Positive Action funded grants and document the impact of each intervention on global, regional, and local HIV prevention and harm reduction goals.
Objectives
- The objectives of the research are the following:
- To evaluate the success of the eight grants based on a review of their achievements versus plan.
- To evaluate the achievements of the eight projects at an outcome and impact level, including.
- Outcome level
- The success of the projects to increase the target population’s knowledge of safe chemsex practices.
- The success of the projects to increase uptake of harm reduction and HIV prevention, care, and treatment services amongst the target populations.
- The success of the projects to increase uptake of mental health and wellbeing services.
- Impact level
- Whether the grants led to a decrease in new HIV infections within the target communities.
- Whether the grants led to an increase in the number of people on HIV treatment, adhering to treatment and achieving viral suppression.
- Whether the grants led to improved mental well-being of individuals that engage in chemsex.
- Outcome level
- To evaluate any trends of interventions that work and show promising practice, as a group of projects
- To assess (and demonstrate) the scalability and/or transferability of the interventions invested in, in process and results, for other setting within and beyond the study countries.
Funding Information
- The maximum budget for the complete work, inclusive of all costs, is 150,000 GBP over the full duration of the research project.
Deliverables
- A research plan outlining the work plan, tools, and methodologies to be used. This would include an outline of methodologies proposed for the end of project evaluation.
- A funding round log-frame.
- Data collection tools and processes that can be implemented by Positive Action grantees.
- Training and ongoing support to Positive Action grantees on the use of relevant data collection tools and processes.
- Ethics approval for the end of project evaluation
- Research findings report containing an executive summary and comprehensive but concise outline of the results of the research study.
- Slide deck that provides and overview of the findings, lessons learnt and recommendations.
- One published journal article.
- One conference paper/presentation.
Eligibility Criteria
- They are looking for a research entity that can demonstrate the following:
- Is based in South East Asia, preferably in one of the countries that will implement one of the Positive Action funded projects to be assessed (Cambodia, Vietnam, Malaysia, the Philippines, and Indonesia).
- Has carried out previous research in HIV and/or harm reduction.
- Has carried out previous research with key populations (sex workers, the LGBTQI+ community and people who use drugs).
- Has robust policies and systems in place to obtain appropriate consent for research, as well as protect sensitive data.
- Can write reports and other assets in English.
For more information, visit ViiV Healthcare.